Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug

Biodegradable and biocompatible polymers that are engineered to nanostructures play a key role in providing solution for sustained chemotherapy. This study is focused on preparation, drug encapsulation efficiency, in‐vitro drug release, in‐vitro cellular uptake and cell viability of poly(caprolacton...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomedical materials research. Part A Vol. 90A; no. 4; pp. 1128 - 1136
Main Authors: Prabu, P., Chaudhari, Atul A., Dharmaraj, N., Khil, M. S., Park, S. Y., Kim, H. Y.
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 15-09-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Biodegradable and biocompatible polymers that are engineered to nanostructures play a key role in providing solution for sustained chemotherapy. This study is focused on preparation, drug encapsulation efficiency, in‐vitro drug release, in‐vitro cellular uptake and cell viability of poly(caprolactone) grafted dextran (PGD) nanoparticles (NPs) formulation containing vinblastine as the anticancer drug. Drug‐loaded PGD NPs were prepared by a modified oil/water emulsion method and characterized by laser light scattering, atomic force microscopy (AFM), and zeta potential. The drug encapsulation efficiency was determined spectrophotometrically and in‐vitro drug release was estimated using dialysis bag. Breast cancer cell line (MCF‐7) was used to image and measure the cellular uptake of fluorescent PGD NPs. Cancer cell viability was assessed by treating MCF‐7 cells with vinblastine‐loaded PGD NPs by crystal violet staining method. Result showed that the vinblastine‐loaded PGD NPs were superior in properties such as drug encapsulation efficiency, the cellular uptake and the cancer cell mortality. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
Bibliography:ark:/67375/WNG-BLX3Q9FJ-R
ArticleID:JBM32163
MOEHRD, The Center for Health Care Technology Development
The Ministry of Commerce, Industry and Energy Department - No. 10028211
istex:9DDD803307AB327B2FDE412E87A79533E0FC13C1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1549-3296
1552-4965
DOI:10.1002/jbm.a.32163